½ÃÀ庸°í¼­
»óǰÄÚµå
1547514

¼¼°èÀÇ ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)

Global Oncology Information System Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 170 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 33¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2032³â 68¾ï 8,000¸¸ ´Þ·¯¿¡ À°¹ÚÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, 2024-2032³â°£ 8.47%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾ÏÁ¤º¸ ½Ã½ºÅÛÀ̶õ Ä¡·á ½Ã¼ú, Ä¡·á Á¦°ø, Ä¡·á ÀÏÁ¤, Ä¡·á °èȹ µî°ú °ü·ÃµÈ ȯÀÚÀÇ ¸ðµç Á¤º¸¸¦ ÇÑ °÷¿¡ ¸ð¾Æ º¸°üÇÏ´Â Ç÷§ÆûÀ» ¸»ÇÕ´Ï´Ù. ¾Ï°ú °°Àº Áúº´Àº º¯È­Çϱ⠽±±â ¶§¹®¿¡ ¸é¹ÐÇÑ ¸ð´ÏÅ͸µ°ú Á¤±âÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ ¶§¹®¿¡ ¾ÏÁ¤º¸ ½Ã½ºÅÛÀº ȯÀÚ Áß½ÉÀûÀÎ ½Ã½ºÅÛÀ̶ó°í ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ ½Ã½ºÅÛÀº ¿µ»óÀÇÇаú, ³»°ú, ¿Ü°ú µî ¿©·¯ Áø·á°ú °£ÀÇ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» ÅëÇÕÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ¿øÈ°ÇÑ ¿¬°á¼ºÀ» Á¦°øÇÏ°í º´¿ø °£ ȯÀÚ µ¥ÀÌÅÍ Àü¼ÛÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ±×·¯³ª ¾ÏÁ¤º¸ ½Ã½ºÅÛÀÇ ³ôÀº ÀÎÇÁ¶ó ºñ¿ë°ú »óÈ£¿î¿ë¼ºÀº ¿¹»êÀÌ ÀûÀº ¼Ò±Ô¸ð º´¿ø¿¡¼­´Â ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

Àü ¼¼°è °í·É ȯÀÚ Áõ°¡¿Í ¾Ï À¯º´·ü Áõ°¡´Â ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀü°ú ¿¬±¸ »ê¾÷¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù. ¾ÏÁ¤º¸ ½Ã½ºÅÛÀº ȯÀÚ µ¥ÀÌÅÍ, Ä¡·á ÀÏÁ¤, º´·Â, Ä¡·á °èȹ µî ´Ù¾çÇÑ °ÍÀ» ½±°Ô ÅëÇÕÇÒ ¼ö Àֱ⠶§¹®¿¡ OIS ½ÃÀåÀº ¹Ì·¡°¡ À¯¸ÁÇÕ´Ï´Ù. ¶ÇÇÑ ¸¶ÄÉÆÃ, È«º¸ ¹× ºê·£µùÀ» À§ÇÑ Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¾ÏÁ¤º¸ ½Ã½ºÅÛÀ» ÃËÁøÇÏ´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°èÀÇ ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÏÁ¤º¸ ½Ã½ºÅÛ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡º°, Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ Å¸°ÙÃþÀ» ½Äº°Çϰí ÇâÈÄ ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ÀúÈñ¿¡°Ô ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå ¾ÏÁ¤º¸ ½Ã½ºÅÛ - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • ¾÷°è µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½ºº°

  • Á¦Ç° ¹× ¼­ºñ½ºº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Á¦Ç° ¹× ¼­ºñ½ºº° ºÐ¼®
  • ¼Ö·ç¼Ç(ȯÀÚ Á¤º¸ ½Ã½ºÅÛ, Ä¡·á °èȹ ½Ã½ºÅÛ)
  • Àü¹® ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¿ëµµº° ºÐ¼®
  • ÀÇ·á ¾Ï
  • ¹æ»ç¼± ¾Ï
  • ¿Ü°ú ¾Ï

Á¦7Àå ¼¼°èÀÇ ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • ÃÖÁ¾»ç¿ëÀÚº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾»ç¿ëÀÚº° ºÐ¼®
  • º´¿ø ¹× ¿µ»ó Áø´Ü¼¾ÅÍ
  • ÀýÁ¦ ÄÉ¾î ¼¾ÅÍ ¹× ¾ÏÄ¡·á ¼¾ÅÍ
  • Á¤ºÎ±â°ü
  • ¿¬±¸½Ã¼³

Á¦8Àå ¼¼°èÀÇ ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ºÐ¼®°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º° ¸®½ºÆ®
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ¾ÏÁ¤º¸ ½Ã½ºÅÛ ±â¾÷ °æÀï ±¸µµ

  • ¾ÏÁ¤º¸ ½Ã½ºÅÛ ½ÃÀå °æÀï
  • Á¦ÈÞ/Çù·Â/ÇÕÀÇ
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Elekta AB
  • Accuray Inc.
  • Varian Medical Systems
  • RaySearch Laboratories
  • Cerner Corp.
  • BrainLab
  • Philips Healthcare
  • Prowess Inc.
  • DOSIsoft S.A.
  • ViewRay Inc.
  • MIM Software And Flatiron
  • McKesson Corporation
  • Siemens Medical Solutions Inc
LSH 24.09.24

The global demand for Oncology Information System Market is presumed to reach the market size of nearly USD 6.88 Billion by 2032 from USD 3.31 Billion in 2023 with a CAGR of 8.47% under the study period 2024-2032.

An oncology information system is a platform that holds all the information of the patient related to treatment procedure, treatment delivery, treatment schedules, and plans, etc. in a single place. The variable nature of diseases like cancer requires close monitoring and regular treatment. This makes the oncology information systems more patient-centered. Moreover, this system is capable of integrating communication between several departments like radiation, medical and, surgical departments. So, it provides seamless connectivity and makes it easy to transfer patient's data between the hospitals. However, high infrastructural cost and interoperability of oncology information systems may give hardship to small hospitals with low budgets.

MARKET DYNAMICS

A worldwide increment in the number of geriatric patients and the rising prevalence of cancer is the primitive reason for the growth of the oncology information system market. The increased investment in the advancement of technology and the research industry will also flourish the market's growth. OIS market has a promising future because oncology information systems can easily integrate several things like managing the patient's data, treatment schedule, medical history, and treatment plans, etc. this advantage makes them preferable by the experts and a reason to drive the market growth. Also, the strategic initiatives taken for marketing, promoting, and branding is supposed to spur the market's growth. The government's initiatives to drive oncology information systems will further stimulate market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oncology Information System. The growth and trends of Oncology Information System industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Oncology Information System market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Products & Services

  • Solutions (Patient Information Systems, Treatment Planning Systems)
  • Professional Services

By Application

  • Medical Oncology
  • Radiation Oncology
  • Surgical Oncology

By End User

  • Hospitals & Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Oncology Information System market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oncology Information System market include Elekta AB, Accuray Inc., Varian Medical Systems, RaySearch Laboratories, Cerner Corp., BrainLab, Philips Healthcare, Prowess Inc., DOSIsoft S.A., ViewRay Inc., MIM Software And Flatiron, McKesson Corporation, Siemens Medical Solutions Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ONCOLOGY INFORMATION SYSTEM - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Products & Services
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET ANALYSIS BY PRODUCTS & SERVICES

  • 5.1. Overview By Products & Services
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Products & Services
  • 5.4. Solutions (Patient Information Systems, Treatment Planning Systems) Historic and Forecast Sales By Regions
  • 5.5. Professional Services Historic and Forecast Sales By Regions

6. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Medical Oncology Historic and Forecast Sales By Regions
  • 6.5. Radiation Oncology Historic and Forecast Sales By Regions
  • 6.6. Surgical Oncology Historic and Forecast Sales By Regions

7. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET ANALYSIS BY END USER

  • 7.1. Overview By End User
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By End User
  • 7.4. Hospitals & Diagnostic Imaging Centers Historic and Forecast Sales By Regions
  • 7.5. Ablation Care Centers and Cancer Care Centers Historic and Forecast Sales By Regions
  • 7.6. Government Institutions Historic and Forecast Sales By Regions
  • 7.7. Research Facilities Historic and Forecast Sales By Regions

8. GLOBAL ONCOLOGY INFORMATION SYSTEM MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ONCOLOGY INFORMATION SYSTEM COMPANIES

  • 9.1. Oncology Information System Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF ONCOLOGY INFORMATION SYSTEM INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Elekta AB
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Accuray Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Varian Medical Systems
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. RaySearch Laboratories
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Cerner Corp.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. BrainLab
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Philips Healthcare
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Prowess Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. DOSIsoft S.A.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. ViewRay Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. MIM Software And Flatiron
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. McKesson Corporation
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Siemens Medical Solutions Inc
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦